scispace - formally typeset
Journal ArticleDOI

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies

Reads0
Chats0
TLDR
Overall, high pretreatment blood NLR could be an adverse prognostic indicator for advanced tumor and large-scale prospective studies investigating its survival outcomes in specific cancer type are strongly advocated.
About
This article is published in Cancer Treatment Reviews.The article was published on 2017-07-01. It has received 209 citations till now. The article focuses on the topics: Hazard ratio.

read more

Citations
More filters
Journal ArticleDOI

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.

TL;DR: The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leuk Openia, which were significantly different between the mild/moderate and severe CO VID-19 groups.
Journal ArticleDOI

Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies

TL;DR: Although the NLR and TAN hold clinical promise in their association with poor cancer prognosis, further research is required to provide robust evidence, assess causality and test clinical utility.
Journal ArticleDOI

Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)

TL;DR: The authors review the biomarker PD‐L1 as well as other emerging and investigational tissue‐based and serum‐based markers that have potential to better predict responders to immunotherapy.
Journal ArticleDOI

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.

TL;DR: Hematologic parameter such as systemic immune‐inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to-lymphocytes ratio (PLR) is associated with nivolumab efficacy in advanced non‐small‐cell lung cancer (NSCLC).
Journal ArticleDOI

Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer

TL;DR: NLR may have greater prognostic value in patients with certain demographic and clinical features, after further characterization of populations in which NLR has maximum prognostic potential and the identification of meaningful thresholds for risk stratification.
References
More filters
Journal ArticleDOI

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.

TL;DR: The neutrophil to lymphocyte ratio (NLR) was recently shown to be a remarkable prognostic factor in tumors, but the combined prognostic value of NLR and PLR in non‐small cell lung cancer (NSCLC) is not clear.
Journal ArticleDOI

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

TL;DR: It is confirmed that high NLR status had a significant negative prognostic effect in the REAL-2 trial population and this effect was independent of other known prognostic factors.
Journal ArticleDOI

Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.

TL;DR: MRI diagnosis of mucinous adenocarcinoma is diagnostically superior to preoperative biopsy and occurs in up to 20% of rectal cancer patients and is an independent imaging biomarker for response to pre operative chemoradiotherapy (CRT) and prognosis.
Journal ArticleDOI

The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study

TL;DR: Inflammatory markers were statistically associated with malnutrition and Malnutrition and mGPS were significant independent predictors of overall survival in patients with advanced cancer.
Related Papers (5)